Document is current
Any future updates will be listed below
-
Authors
Nedeljkovic, David
Ostojic, Sergej M. https://orcid.org/0000-0002-7270-2541
-
Funding
Funding for this research was provided by:
University of Pécs
- License Information
-
More Information
Article History
Received: 16 March 2025
Accepted: 6 May 2025
First Online: 24 May 2025
Declarations
:
: Ethical approval for the NHANES study was granted by the National Center for Health Statistics Ethics Review Board. Informed consent was obtained from all participants prior to their inclusion in the study. The research was conducted ethically following the World Medical Association Declaration of Helsinki.
: DN declares no known competing financial interests or personal relationships that could have appeared to influence the authorship of this paper. SMO serves as a member of the Scientific Advisory Board on Creatine in Health and Medicine (AlzChem LLC). SMO co-owns patent “Supplements Based on Liquid Creatine” at the European Patent Office (WO2019150323 A1) and patent application “Composition Comprising Creatine for Use in Telomere Lengthening” at the U.S. Patent and Trademark Office (# 63/608,850). SMO has received research support related to creatine during the past 36 months from the Serbian Ministry of Science, Technological Development and Innovation; Provincial Secretariat for Higher Education and Scientific Research; AlzChem GmbH; Kaneka Nutrients; ThermoLife International, and Vireo System Inc. SMO does not own stocks and shares in any organization.
